Location: Research Report > All Reports > Medical and Health > Medicine and Pharmacy

China Anti-tumor Drug Industry Market Prospects and Investment Strategy Planning Report, 2013-2017

Last Update:2014-05-14

Form of services:Book + (pdf or doc file) + CD

Send method:EMS 2-3 days for delivery

English Service:+86 0755 33220413

Chinese Service:+86 800-8306390 800-8306395

E-mail:service.en@qianzhan.com

Report price:$7900 Print: $7800 CD: $7800

Special statement:

Recently we find there are some sites steal report contents from Qianzhan.com who put those contents on their sites for sale by making a little changes about the contents or remaining the same which deceives buyers(e.g. unable to get full or correct reports, or main body differs from contents that announced on sites).Therefore, we recommend paying a visit to Qianzhan personally or by your friends, and make payment after confirmation. Special statement: Qianzhan is the only and right holder of all the research reports, and has never used a third party to sell any reports, please be aware of the trademark " " when purchasing. Qianzhan is the largest and strongest consultancy, who owns the greatest number of researchers. Here followed "Nine standards of companies' identificatios"。

This table of content is original, without written permission of Qianzhan, any unit or individual shall not use, copy, or transfer the reports.

Preface

Table of Content

Under the circumstances of environmental pollution, deepening of aging degree, and increasing working and living pressure, there are more and more patients suffering from tumor diseases in China, which stimulates the fast development of tumor drugs market. With such background, the domestic excellent anti-tumor drugs manufacturers pay more attention to the industry market research, especially to the in-depth researches on the industry development environment and customer demand trend changes. Because of this, a large number of excellent anti-tumor drug brands rise up rapidly, and gradually become leading corporations in anti-tumor drug industry!

With Forward’s long-term tracking and collecting market data of anti-tumor drug industry, we roundly and accurately analyze the industry structure system for you from the view of mastering the whole industry. On the basis of analyzing the scale of anti-tumor drug industry, this report mainly focuses on firstly analyzing the development scale, competitive landscape of China anti-tumor drug industry and its markets of major anti-tumor drugs. Next, it conducts research on the prevalence rate, consultation rate and mortality of patients suffering from tumor disease. On this basis, it performs an analysis on overall tumor medical service market and major demand for tumor medical market. Then it analyzes some domestic anti-tumor drug enterprises, from the perspectives of operation status, market position of anti-tumor drugs, R&D capability, and researchable products, etc. At last, it forecasts the development prospects for industry based on its development driving factors and development trend, moreover, it analyzes the investment status, investment strategy and risk tips for the industry.

The most distinctive characteristics of this report is forward-looking and timeliness. Based on future development tracks and years’ practice experience of anti-tumor drug industry, we conduct prudent analysis and forecast for anti-tumor drug industry’s future development trend. This report helps anti-tumor drug manufacturers, R&D institutions, marketing enterprises and investment enterprises to precisely grasp current latest developments of the industry.

This report will help anti-tumor drug manufacturers, R&D institutions, marketing enterprises and investment enterprises precisely grasp the latest development trend, and find the blank, opportunity, growth, profit spots and others in the market of industry in advance, and grasp the market demand and trends that has not been found in the perspective of forward-looking. It also helps form a sustainable development advantage, effectively avoid investment risks in the industry, effectively consolidate or extend according strategic target markets, and firmly hold the initiative right to compete.

Here, we would like to express our sincere gratitude to Ministry of Public Health, Ministry of State Information Center, Bureau of Statistics of China, China Customs, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council and Beijing Essence Forward Research Center, for their great support when we conduct this report!

Notice: All the market data, especially corporations’ ranking data in the report, only for business reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!

Special tips: Ignoring some subtle hints in the violent change of external environment, and failure of updating strategic decisions timely will finally lead to the loss of competitive advantage. A true successful company will make scientific researches on external environment consciously or unconsciously, so as to formulate a key scientific operating strategy!

Best wishes for every enterprise with a big dream that can draw up a high-quality operating decision, to effectively avoid the risks and continuously gain the success.

Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Anti-tumor Drug Industry

Chapter 1: Development Overview of Anti-tumor Drug Industry

1.1 Research Background and Methods for Report

1.1.1 Introduction of Research Departments for Report

1.1.2 Research Background of Report

1.1.3 Overview of Research Methods

(1) Statistic Standards for Data

(2) Concept of Research Methods

1.2 Overview of Anti-tumor Drug Industry

1.2.1 Concept and Classification of Tumor

(1) Concept of Tumor

(2) Classification of Tumor

1.2.2 Classification of Antineoplastic Drugs

1.3 Policy Environment for Antineoplastic Drugs

1.3.1 Supervision System for Antineoplastic Drugs

1.3.2 Policies Related to Anti-tumor Drug Industry

(1) Policies and Regulations Related to Anti-tumor Drug Industry

(2) Explanation of Policies Related to the Industry

1.3.3 Impact of New Reform on the Industry

1.3.4 Policy Forecast for Anti-tumor Drug Industry

1.4 Financial Conditions of Anti-tumor Drug Industry

1.4.1 Growth of Domestic GDP Growth

1.4.2 Income of Residential Income

1.4.3 Residential Consumption Level

1.4.4 Residential Medical Care

1.4.5 Development Forecast for Macro-economy

1.5 Social Environment for Anti-tumor Drug Industry

1.5.1 Population Growth and Aging Trend

1.5.2 Tumor Disease and Environmental Pollution

1.6 Technical Environment for Anti-tumor Drug Industry

1.6.1 Technical Environment Status

1.6.2 Patent Technology of Anti-tumor Drug Industry

Chapter 2: Analysis of Development Situation of Anti-tumor Drug Industry

2.1 Development Overview of International Anti-tumor Drug Industry

2.1.1 Development Size of International Anti-tumor Drug Industry

2.1.2 Competitive Landscape of International Anti-tumor Drug Industry

2.1.3 Development Trend for International Anti-tumor Drug Industry

2.2 Development Status of Domestic Anti-tumor Drug Industry

2.2.1 Development History of Anti-tumor Drug Industry

2.2.2 Development Size of Anti-tumor Drug Industry

2.2.3 Development Trend for Anti-tumor Drug Industry

2.3 Competitive Landscape of Anti-tumor Drug Industry

2.3.1 Market Pattern of Anti-tumor Drug Industry

2.3.2 Proportion of Product in Anti-tumor Drug Industry

2.3.3 Core Competitive Factors of Anti-tumor Drug Industry

2.3.4 Potential Entrants of Anti-tumor Drug Industry

Chapter 3: Analysis of Product Market of Anti-tumor Drug Industry

3.1 Analysis of Chemical Antineoplastic Drugs Market

3.1.1 Analysis of Natural Antineoplastic Drugs Market

(1) Docetaxel Market